Effects of S-8510, a novel benzodiazepine receptor partial inverse agonist, on basal forebrain lesioning-induced dysfunction in rats.

We investigated the effects of a novel benzodiazepine partial inverse agonist, S-8510 (2-(3-isoxazolyl)-3,6,7,9-tetrahydroimidazo [4,5-d] pyrano [4,3-b] pyridine monophosphate monohydrate), on the impairment of spatial memory, decreased high-affinity choline uptake and acetylcholine release in basal forebrain-lesioned rats. S-8510 (3 and 5 mg/kg, p.o. 30 min before each training session) significantly ameliorated the basal forebrain-lesion-induced impairment of spatial memory in water maze task. In vivo brain microdialysis studies showed that systemic administration of S-8510 at 3 and 10 mg/kg significantly increased the release of acetylcholine in the front-parietal cortex in basal forebrain-lesioned rats. Further, repeated administration of S-8510 (3 and 10 mg kg(-1) day(-1) for 5 days) reversed the decrease in cortical high-affinity choline uptake induced by basal forebrain lesion. Thus, S-8510 improved the spatial memory impairment induced by lesion of the basal forebrain in rats. In addition, it increased acetylcholine release and high-affinity choline uptake from the cortex, a region closely associated with memory, in basal forebrain-lesioned rats. These results indicate that S-8510 has cognition enhancing and cholinergic-activating effects in the basal forebrain-lesioned rats, suggesting that this agent may be useful for the treatment of mild to moderate senile dementia including Alzheimer's disease.

[1]  I. Izquierdo,et al.  Habituation and inhibitory avoidance training alter brain regional levels of benzodiazepine-like molecules and are affected by intracerebral flumazenil microinjection , 1991, Brain Research.

[2]  L. Heimer,et al.  GABAergic input to cholinergic forebrain neurons: An ultrastructural study using retrograde tracing of HRP and double immunolabeling , 1986, The Journal of comparative neurology.

[3]  C. Braestrup,et al.  Ligands for benzodiazepine receptors with positive and negative efficacy. , 1984, Biochemical pharmacology.

[4]  D. Neary,et al.  Catecholaminergic neurones assessed ante-mortem in Alzheimer's disease , 1987, Brain Research.

[5]  J. Kehne,et al.  MDL 26,479: a potential cognition enhancer with benzodiazepine inverse agonist‐like properties , 1992, British journal of pharmacology.

[6]  J. Miller,et al.  The regulation of high-affinity choline uptake in vitro in rat cortical and hippocampal synaptosomes by β-carbolines administered in vivo , 1990, Neuroscience Letters.

[7]  D. Lahiri,et al.  Tacrine alters the secretion of the beta‐amyloid precursor protein in cell lines , 1994, Journal of neuroscience research.

[8]  M. Sarter,et al.  Spontaneous exploration of a 6-arm radial tunnel maze by basal forebrain lesioned rats: effects of the benzodiazepine receptor antagonist β-carboline ZK 93 426 , 2004, Psychopharmacology.

[9]  D. Neary,et al.  Presynaptic Cholinergic Dysfunction in Patients with Dementia , 1983, Journal of neurochemistry.

[10]  M. Sarter,et al.  Bidirectional effects of β-carbolines and benzodiazepines on cognitive processes , 1987, Brain Research Bulletin.

[11]  H. Moore,et al.  Bidirectional modulation of stimulated cortical acetylcholine release by benzodiazepine receptor ligands , 1993, Brain Research.

[12]  J. Growdon,et al.  Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. , 1992, Science.

[13]  Kenneth S. Kosik,et al.  Alzheimer plaques and tangles: advances on both fronts , 1991, Trends in Neurosciences.

[14]  J. Rossier,et al.  Benzodiazepine impairs and β-carboline enhances performance in learning and memory tasks , 1986, Nature.

[15]  P. Greengard,et al.  Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[16]  F. Fonnum,et al.  A rapid radiochemical method for the determination of choline acetyltransferase , 1975, Journal of neurochemistry.

[17]  M. Kuhar,et al.  SODIUM‐DEPENDENT HIGH AFFINITY CHOLINE UPTAKE: A REGULATORY STEP IN THE SYNTHESIS OF ACETYLCHOLINE , 1976, Journal of neurochemistry.

[18]  H. S. Koelega.  Benzodiazepines and vigilance performance: a review , 2004, Psychopharmacology.

[19]  J. Simon,et al.  High‐Affinity Choline Uptake in the Hippocampus: Its Relationship to the Physiological State Produced by Administration of Barbiturates and Other Treatments , 1982, Journal of neurochemistry.

[20]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[21]  M. Thiébot.  Some evidence for amnesic-like effects of benzodiazepines in animals , 1985, Neuroscience & Biobehavioral Reviews.

[22]  P. Dudchenko,et al.  Interactions between the effects of basal forebrain lesions and chronic treatment with MDL 26,479 on learning and markers of cholinergic transmission , 1993, Brain Research.

[23]  M. Sarter,et al.  High density of benzodiazepine binding sites in the substantia innominata of the rat , 1988, Pharmacology Biochemistry and Behavior.

[24]  M. Sarter,et al.  Treatment strategies for senile dementia: antagonist β-carbolines , 1988, Trends in Neurosciences.

[25]  Attenuation by the benzodiazepine receptor antagonist, ZK 93 426, of the deficit in spatial navigation induced by nucleus basalis lesions. , 1992, Behavioral and neural biology.

[26]  J. Coyle,et al.  Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. , 1982, Science.

[27]  A. D. Smith,et al.  GABA‐immunoreactive synaptic boutons in the rat basal forebrain: Comparison of neurons that project to the neocortex with pallidosubthalamic neurons , 1988, The Journal of comparative neurology.

[28]  Larry L. Butcher,et al.  Cholinergic projections from the basal forebrain to frontal, parietal, temporal, occipital, and cingulate cortices: A combined fluorescent tracer and acetylcholinesterase analysis , 1982, Brain Research Bulletin.

[29]  S. File,et al.  Low and high doses of benzodiazepine receptor inverse agonists respectively improve and impair performance in passive avoidance but do not affect habituation , 1988, Behavioural Brain Research.

[30]  B. Winblad,et al.  Transmitter deficits in Alzheimer's disease , 1985, Neurochemistry International.

[31]  I. Izquierdo,et al.  GABAA receptor modulation of memory: the role of endogenous benzodiazepines. , 1991, Trends in pharmacological sciences.

[32]  I. Izquierdo,et al.  The effect of flumazenil on acquisition, retention, and retrieval of spatial information. , 1991, Behavioral and neural biology.

[33]  H. Hodges,et al.  Improved radial maze performance induced by the benzodiazepine antagonist ZK 93 426 in lesioned and alcohol‐treated rats , 1989, Behavioural pharmacology.

[34]  J. Axelrod,et al.  Muscarinic Acetylcholine Receptor Subtypes Associated with Release of Alzheimer Amyloid Precursor Derivatives Activate Multiple Signal Transduction Pathways , 1993, Annals of the New York Academy of Sciences.

[35]  D L Price,et al.  Alzheimer's disease: a disorder of cortical cholinergic innervation. , 1983, Science.

[36]  J. Hardy,et al.  Amyloid deposition as the central event in the aetiology of Alzheimer's disease. , 1991, Trends in pharmacological sciences.

[37]  T. J. Walsh,et al.  Intraseptal injection of GABA and benzodiazepine receptor ligands alters highaffinity choline transport in the hippocampus , 1993, Brain Research Bulletin.

[38]  M. Sarter,et al.  Trans-synaptic stimulation of cortical acetylcholine and enhancement of attentional functions: a rational approach for the development of cognition enhancers , 1997, Behavioural Brain Research.

[39]  K. Kawasaki,et al.  A novel benzodiazepine inverse agonist, S-8510, as a cognitive enhancer , 1996, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[40]  M. Forster,et al.  CGS 8216, a benzodiazepine receptor antagonist, enhances learning and memory in mice , 1988, Brain Research.

[41]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[42]  G. Biggio,et al.  The benzodiazepine receptor antagonist flumazenil increases acetylcholine release in rat hippocampus , 1994, Brain Research.

[43]  E K Perry,et al.  Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. , 1978, British medical journal.

[44]  K. Abe,et al.  Potentiation by DSP-4 of EEG slowing and memory impairment in basal forebrain-lesioned rats. , 1997, European journal of pharmacology.